SCHEMBL30697451

SCHEMBL30697451

COC(=O)c1ccnc2cc[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 2/20 0.45
▸ NUDT1 P36639 1/20 0.44
▸ MAP2K1 Q02750 1/20 0.44
▸ KDM4E B2RXH2 5/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ PSMD14 O00487 1/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ PIM3 Q86V86 2/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ KDM5B Q9UGL1 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ AXL P30530 1/20 0.38
▸ NR4A2 P43354 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28909033 0.80 CHEK1 (0.45) KDM5ANUDT1MAP2K1KDM4EALDH1A1
SCHEMBL29696528 0.80 KDM5A (0.51) KDM5AKDM5B
SCHEMBL16150881 0.80 KDM5A (0.51) KDM5AKDM5B
SCHEMBL29696445 0.78 BTK (0.52) NUDT1MAP2K1KDM4EMAPK1L3MBTL1
SCHEMBL19231054 0.78 BTK (0.52) NUDT1MAP2K1KDM4EMAPK1L3MBTL1
SCHEMBL29738256 0.76 TSHR (0.49) KDM5AMAP2K1KDM4EALDH1A1GAA
SCHEMBL26233949 0.76 TSHR (0.49) KDM5AMAP2K1KDM4EALDH1A1GAA
SCHEMBL7497434 0.76 PIM3 (0.55) NUDT1MAP2K1KDM4EALDH1A1GAA
SCHEMBL1951650 0.75 NUDT1 (0.73) NUDT1MAP2K1KDM4EALDH1A1GAA
SCHEMBL29702772 0.75 NUDT1 (0.73) NUDT1MAP2K1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110891935-B Bicyclic compounds and their use in cancer treatment 泰普斯特医疗公司 2023-12-01 — — CN disclosed
Send feedback